Bioline Rx reported $360K in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Arca Biopharma USD 504K 246K Sep/2024
Bio Path 130K 95K Sep/2025
Bioline Rx USD 360K 84K Sep/2025
Capricor Therapeutics 3.05M 2.46M Dec/2025